Biofrontera AG (GB:0DOL)
LSE:0DOL
Holding GB:0DOL?
Track your performance easily

Biofrontera (0DOL) Share Price & Analysis

0 Followers

0DOL Stock Chart & Stats


Financials

Annual

0DOL FAQ

What was Biofrontera AG’s price range in the past 12 months?
Biofrontera AG lowest share price was €14.30 and its highest was €14.30 in the past 12 months.
    What is Biofrontera AG’s market cap?
    Currently, no data Available
    When is Biofrontera AG’s upcoming earnings report date?
    Biofrontera AG’s upcoming earnings report date is Apr 24, 2025 which is in 161 days.
      How were Biofrontera AG’s earnings last quarter?
      Currently, no data Available
      Is Biofrontera AG overvalued?
      According to Wall Street analysts Biofrontera AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Biofrontera AG pay dividends?
        Biofrontera AG does not currently pay dividends.
        What is Biofrontera AG’s EPS estimate?
        Biofrontera AG’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Biofrontera AG have?
        Biofrontera AG has 6,076,862 shares outstanding.
          What happened to Biofrontera AG’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Biofrontera AG?
          Currently, no hedge funds are holding shares in GB:0DOL
          ---

          Biofrontera Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Positive
          20 days / 200 days
          Momentum
          0.00%
          12-Months-Change

          Fundamentals

          Return on Equity
          -14.71%
          Trailing 12-Months
          Asset Growth
          -12.31%
          Trailing 12-Months

          Company Description

          Biofrontera AG

          Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          HemoGenyx Pharmaceuticals Plc
          Sareum Holdings
          Creo Medical
          Futura Medical
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis